Viewing Study NCT06234956


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-04-02 @ 4:05 PM
Study NCT ID: NCT06234956
Status: COMPLETED
Last Update Posted: 2025-09-16
First Post: 2023-10-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.
Sponsor: Hipra Scientific, S.L.U
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module